Hepatitis Test Kits

Accuquik is a CE,ISO, USFDA Hepatitis Test Kits manufacturer
As an American brand, AccuQuik™ places the highest priority on the quality of our Hepatitis Test Kit products. However,
as we look to serve the needs of the developing world, our test kits are manufactured in our India and China based facilities.

Hepatitis Test Kits

Accuquik is a CE,ISO, USFDA Hepatitis Test Kits manufacturer
As an American brand, AccuQuik™ places the highest priority on the quality of our Hepatitis Test Kit products. However,
as we look to serve the needs of the developing world, our test kits are manufactured in our India and China based facilities.

Hepatitis Test Kits Features


Tests: Hepatitis A Virus-IgM Test, HBsAb Hepatitis B Surface Antibody Test (Cassette Only), HBsAg Ultra Hepatitis B Surface Antibody Test, Hepatitis C Virus Test, Hepatitis E Virus IgM Test

Disease: Hepatitis A, B, C, E

Specimen: Serum/Plasma, Whole Blood

Sensitivity: Test Dependent – See Catalog

Test Form: Cassette, Strips

Packaging:
  • 1 strip/pack, 50 packs/box
  • 1 cassette/pack, 25 packs/box
  • 1 cassette/complete set, 1 set/box

Hepatitis Test Kits

Choose Specification

Test
Specimen
Form
Hepatitis Test Kits

More Information about the Test and Hepatitis


The hepatitis diagnostic test kits detect antibodies in the serum/plasma or blood through the use of specific complementary antibody markers. Diagnosis consists of one screening test.

The hepatitis A IgM virus test detects the IgM antibodies produced by the body in defense against the virus. The HBsAb hepatitis B surface antibody test detects the antibodies complementary to the hepatitis B antigens presented on cells during infection by the hepatitis B virus. The hepatitis C virus test detects cells of the immune system raised specifically against the hepatitis C virus. The hepatitis E IgM virus test detects the IgM antibodies produced by the immune system in defense against the hepatitis E virus.

The test time varies depending on which test is taken. In the case of a hepatitis-positive result one should consult with their doctor to consider the first stage of treatment. Our hepatitis test kits have been shown to be accurate in 98-99% of cases, clearly demonstrating their reliability. However, several conditions can change the hepatitis antibody levels and so we recommend consultation with a doctor to discuss abnormal results. Certain factors may influence the result of the test, for instance some herbs or other natural products, possibly requiring the test to be re-administered.

The Hepatitis Test

Available as Cassette or Strips

Hepatitis Test Kits Cassette and Strip Form

The hepatitis diagnostic test kits detect antibodies in the serum/plasma or blood through the use of specific complementary antibody markers. Diagnosis consists of one screening test.

The hepatitis A IgM virus test detects the IgM antibodies produced by the body in defense against the virus. The HBsAb hepatitis B surface antibody test detects the antibodies complementary to the hepatitis B antigens presented on cells during infection by the hepatitis B virus. The hepatitis C virus test detects cells of the immune system raised specifically against the hepatitis C virus. The hepatitis E IgM virus test detects the IgM antibodies produced by the immune system in defense against the hepatitis E virus.

The test time varies depending on which test is taken. In the case of a hepatitis-positive result one should consult with their doctor to consider the first stage of treatment. Our hepatitis test kits have been shown to be accurate in 98-99% of cases, clearly demonstrating their reliability. However, several conditions can change the hepatitis antibody levels and so we recommend consultation with a doctor to discuss abnormal results. Certain factors may influence the result of the test, for instance some herbs or other natural products, possibly requiring the test to be re-administered.

The Disease

General Information

Hepatitis is a medical condition characterized by the inflammation of the liver. The condition occurs in both an asymptomatic and symptomatic state. The disease is defined as acute when the duration is less than 6 months, and chronic when it lasts longer. The condition can be self-limiting or can progress to fibrosis and cirrhosis. There are 5 types of viral hepatitis – A, B, C, D and E. Each type of hepatitis is caused by an unrelated virus that exerts a specific effect on the liver.

HEPATITIS A is an acute illness that can be transmitted through blood and infected bodily fluids. On average the incubation period is 28 days before the acute symptoms begin to develop, including jaundice, abdominal pain, loss of appetite, nausea, fever, diarrhea and fatigue. The disease is highly contagious two weeks before the symptoms appear and during the first week of having symptoms. Hepatitis A can be prevented through the practice of good hygiene and the use of a condom during sexual intercourse. There is also a vaccination (HAV) which is administered in two divided doses. A combination vaccine is available for hepatitis A and B, called Twinrix. In addition immune globulin medication can be prescribed within two weeks of contact with an infected individual.

HEPATITIS B is an acute and chronic illness that can be transmitted through blood and infected bodily fluids. On average the incubation period is 75 days before the acute symptoms begin to develop, including jaundice, abdominal pain, loss of appetite, nausea, fever, diarrhea and fatigue. Chronic symptoms include cirrhosis of the liver and liver cancer. Children below the age of six are those highest at risk. Hepatitis B can be prevented through the practice of good hygiene and the use of a condom during sexual intercourse. There is a vaccination (HBV) which is administered in a series of three to four shots. A combination vaccine called Twinrix is available for hepatitis A and B.

HEPATITIS C is an acute and chronic illness that can be transmitted through blood and infected bodily fluids. On average the incubation period is 40 days before the symptoms begin to develop, including jaundice, abdominal pain, loss of appetite, nausea, joint pain and fatigue. Hepatitis C can be prevented through the practice of good hygiene and the use of a condom during sexual intercourse. There is currently no vaccine against hepatitis C.

HEPATITIS D is an acute and chronic illness that can be transmitted through blood and infected body fluids. Hepatitis D is caused by a sub-viral satellite that requires the helper function of the hepatitis B virus to infect an individual. The presence of both hepatitis D and B viruses can result in either a co-infection, or a super-infection by the HDV. Hepatitis D causes an increased likelihood of liver failure and a rapid progression to liver cirrhosis. HDV also has the highest mortality rate of all the hepatitis diseases, at 20%, with higher risks of transmission by injecting drug users and patients taking clotting factor concentrates. Individuals suffering with chronic hepatitis B carry a high risk of contracting HDV.

HEPATITIS E is an acute illness that can be transmitted through blood and infected bodily fluids. On average the incubation period is 40 days before the acute symptoms begin to develop, including fatigue, loss of appetite, weight loss, abdominal pain, jaundice, muscle soreness and fever. Hepatitis E can be prevented through the practice of good hygiene and the use of a condom during sexual intercourse. A vaccination was produced in 2011 (HEV) however it is not yet globally available.

Hepatitis is highly prevalent in Africa, eastern European countries and Asian countries. The incidence and mortality rates vary with region and virus type. Hepatitis A is the most common with over 300 million infected worldwide. In contrast, hepatitis C has a much lower infection rate but contributes to the most fatalities. Hepatitis D is prevalent in the Mediterranean region, sub-Saharan Africa, Middle East and northern regions of South America.

Treatments

Maintaining an adequate nutritional balance and staying comfortable, including replacement of lost fluids, is recommended for recovery from hepatitis. Hepatitis A, B and E are usually resolved without treatment as there is currently no available medication for these varieties.
Oral anti-viral agents are available for chronic hepatitis B, for example Tenofovir and Entecavir. Interferon injections are also used to treat chronic hepatitis B, which slow the progression of liver cirrhosis, reducing the incidence of hepatocellular cancer and consequently improving long term survival. Hepatitis C can be treated with the one-daily pill Harvoni, which will cure an infected individual within 8-12 weeks, with minor side effects of fatigue and headaches. There is no vaccine against hepatitis D, however vaccination against hepatitis B is the current control method against HDV. Some treatments against hepatitis D use a-interferon to improve the conditions associated with the disease. For serious cases liver transplants should be considered.
For more information on the support available for hepatitis patients:
http://www.hepbhelp.org.au/
http://www.hepb.org/patients/support_groups.htm

Hepatitis Test Kits FAQs



Who needs the hepatitis test kits?
Individuals should be tested for hepatitis if they: have signs or symptoms of liver disease; have ever injected drugs; received a blood transfusion or an organ transplant before 1992; received a blood product used to treat clotting problems that was made before 1987; were born between 1945 and 1965; have long-term kidney dialysis; have HIV; have a known exposure to HCV; been notified to have received blood from a donor who later tested positive for the disease.
Will the hepatitis test kit tell me which type of hepatitis I have?
Each hepatitis test will confirm the presence or absence of that specific type of hepatitis. For example the Hepatitis C Virus Test will confirm whether the individual has hepatitis C, but cannot provide any information on whether the individual has any other type of hepatitis. In order to deduce which type of hepatitis the patient is infected with, specific hepatitis test should be performed.
What does the surface antibody test involve?
The surface antibody test provides qualitative and quantitative results. The test detects hepatitis B surface antibodies, which appear 1-2 months following the onset of symptoms. The appearance of hepatitis B antibodies coincides with the disappearance of hepatitis B antigens (HBsAg), which are the first serologic marker, appearing in the serum 6-16 weeks following HBV infection. A positive result indicates a recovery from HBV or acquired immunity from the HBV vaccination. The positive result is associated with hepatitis B surface antibody levels above 30mlU/ml. A negative result indicates the lack of recovery from HBV or inadequate immune response to the vaccine.
Where can I buy AccuQuik™ hepatitis test kits?
The AccuQuik™ hepatitis test kits can be purchased from any local retailer distributing the products. The tests kits can also be provided for distribution following contact with the sales department of AccuQuik™.
Can I use the hepatitis test kits at home?
The hepatitis tests require either a serum/plasma sample or whole blood sample, both of which require a blood test from the patient. Blood tests should be taken by a qualified professional, using sterile equipment. The test should then be disposed of according to local sanitary regulations to prevent transmission of the infectious disease. The tests are simple and easy to use, but should still be used in a professional environment. The results can be read visually without the need of any instruments.
Are AccuQuik™ hepatitis test kits 100% accurate?
The hepatitis test kits have been shown to be between 98-99% accurate however it is recommended to consult a doctor if the tests show a positive result to confirm the diagnosis, and to consider treatment. The tests are very accurate but are only qualitative filters, as such they should not be used as the final test for the patient.
Do you have any other question about AccuQuik™ hepatitis test kits?